EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cirugía personalizada en oncología: integración de biomarcadores genómicos y terapias vacunales como adyuvantes quirúrgicos

Jorge Angel Velasco Espinal, Andrea Burgos Mondragón, Javier Gerardo Pérez Aparicio, Geamiley Anggeline Atencio Valdez, Perla Rosalba Pineda Arelio, Emmanuel Trujillo Giles, Naomi Aquetzali Domínguez Campos

Star of Sciences Multidisciplinary Journal · 09.07.2025 · 2 (2) · 1-19

DOI: 10.63969/jatvd658 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Star of Sciences Multidisciplinary Journal, online erschienen am 09.07.2025. Verfasst von Jorge Angel Velasco Espinal und 6 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Surgical resection remains the main curative option for many solid tumors, but recurrence is still high due to micrometastatic disease that conventional surgery alone cannot fully remove. Precision oncology now makes it possible to integrate genomic biomarkers and personalized immunological strategies to improve surgical results. This study evaluated combining genomic profiling and personalized neoantigen-based vaccines as perioperative adjuvants to lower recurrence and extend disease-free survival. A documentary, statistical, and experimental approach identified frequent mutations and assessed their immunogenic potential. A binding affinity heatmap predicted interactions between neoantigens and MHC alleles, and an in vitro assay confirmed tumor cell lysis after exposure to the prototype vaccine. Statistical projections and a simulated Kaplan–Meier curve showed that adding a personalized vaccine to biomarker-guided surgery could reduce recurrence by up to 50% and increase disease-free survival from 24 to 40 months. These findings align with existing evidence that neoantigen vaccines help boost the immune response against residual tumor cells, complementing precise surgical removal. Although the results are promising, in vivo studies and clinical trials are needed to confirm safety, real effectiveness, and feasibility, especially in settings with limited genomic resources. This work supports that combining molecular profiling, rational vaccine design, and tailored surgical planning can strengthen precision oncology and offer patients a better chance of achieving long-lasting remission.

Zitieren

APA

Espinal, J. A. V., Mondragón, A. B., Aparicio, J. G. P., Valdez, G. A. A., Arelio, P. R. P., Giles, E. T., & Campos, N. A. D. (2025). Cirugía personalizada en oncología: integración de biomarcadores genómicos y terapias vacunales como adyuvantes quirúrgicos. Star of Sciences Multidisciplinary Journal, 2(2), 1-19. https://doi.org/10.63969/jatvd658

Vancouver

Espinal JAV, Mondragón AB, Aparicio JGP, Valdez GAA, Arelio PRP, Giles ET, et al. Cirugía personalizada en oncología: integración de biomarcadores genómicos y terapias vacunales como adyuvantes quirúrgicos. Star of Sciences Multidisciplinary Journal. 2025;2(2):1-19. doi:10.63969/jatvd658

BibTeX
@article{Espinal2025,
  author = {Espinal, Jorge Angel Velasco and Mondragón, Andrea Burgos and Aparicio, Javier Gerardo Pérez and Valdez, Geamiley Anggeline Atencio and Arelio, Perla Rosalba Pineda and Giles, Emmanuel Trujillo and Campos, Naomi Aquetzali Domínguez},
  title = {Cirugía personalizada en oncología: integración de biomarcadores genómicos y terapias vacunales como adyuvantes quirúrgicos},
  journal = {Star of Sciences Multidisciplinary Journal},
  year = {2025},
  volume = {2},
  number = {2},
  pages = {1--19},
  doi = {10.63969/jatvd658}
}
Kostenlos starten →